1,476 research outputs found
The isolation of VCAM-1+ endothelial cell-derived extracellular vesicles using microfluidics
Background: Vascular cell adhesion molecule-1 (VCAM-1+) endothelial cell-derived extracellular vesicles (EC-EVs) are augmented in cardiovascular disease, where they can signal the deployment of immune cells from the splenic reserve. Endothelial cells in culture activated with pro-inflammatory tumor necrosis factor-α (TNF-a) also release VCAM-1+ EC-EVs. However, isolating VCAM-1+ EC-EVs from conditioned cell culture media for subsequent in-depth analysis remains challenging.
Aim: We utilized the extracellular vesicles (EV) microfluidics herringbone chip (EVHB-Chip), coated with anti-VCAM-1 antibodies, for selective capture of VCAM-1+ cells and EC-EVs.
Methods and Results: Engineered EA.hy926 endothelial cells overexpressing VCAM-1 (P < 0.001 versus control) showed increased binding to the VCAM-1- EVHB-Chip versus an IgG device. TNF-α-stimulated human umbilical cord vein endothelial cells (HUVECs) exhibited elevated VCAM-1 protein levels (P < 0.001) and preferential binding to the VCAM-1- EVHB-Chip versus the IgG device. HUVECs stimulated with TNF-α showed differential gene expression of intercellular adhesion molecule-1 (ICAM-1) (P < 0.001) and VCAM-1 (P < 0.001) by digital droplet PCR versus control cells. HUVEC-derived EC-EVs were positive for CD9, CD63, HSP70, and ALIX and had a modal size of 83.5 nm. Control and TNF-α-stimulated HUVEC-derived EC-EV cultures were captured on the VCAM-1- EVHB-Chip, demonstrating selective capture. VCAM-1+ EC-EV were significantly enriched for ICAM-1 (P < 0.001) mRNA transcripts.
Conclusion: This study presents a novel approach using the EVHB-Chip, coated with anti-VCAM-1 antibodies and digital droplet PCR for the study of VCAM-1+ EC-EVs. Isolation of VCAM-1+ EC-EV from heterogeneous sources such as conditioned cell culture media holds promise for subsequent detailed characterization, and may facilitate the study of VCAM-1+ EC-EVs in cardiovascular and metabolic diseases, for disease monitoring and therapeutic insights
Vanishing Viscous Limits for 3D Navier-Stokes Equations with A Navier-Slip Boundary Condition
In this paper, we investigate the vanishing viscosity limit for solutions to
the Navier-Stokes equations with a Navier slip boundary condition on general
compact and smooth domains in . We first obtain the higher order
regularity estimates for the solutions to Prandtl's equation boundary layers.
Furthermore, we prove that the strong solution to Navier-Stokes equations
converges to the Eulerian one in and
L^\infty((0,T)\times\o), where is independent of the viscosity, provided
that initial velocity is regular enough. Furthermore, rates of convergence are
obtained also.Comment: 45page
Uniform regularity for the Navier-Stokes equation with Navier boundary condition
We prove that there exists an interval of time which is uniform in the
vanishing viscosity limit and for which the Navier-Stokes equation with Navier
boundary condition has a strong solution. This solution is uniformly bounded in
a conormal Sobolev space and has only one normal derivative bounded in
. This allows to get the vanishing viscosity limit to the
incompressible Euler system from a strong compactness argument
Investigation of the evolution of radiation-induced lung damage using serial CT imaging and pulmonary function tests
Background and purpose:
Radiation-induced lung damage (RILD) is a common consequence of lung cancer radiotherapy (RT) with unclear evolution over time. We quantify radiological RILD longitudinally and correlate it with dosimetry and respiratory morbidity.
Materials and methods:
CTs were available pre-RT and at 3, 6, 12 and 24-months post-RT for forty-five subjects enrolled in a phase 1/2 clinical trial of isotoxic, dose-escalated chemoradiotherapy for locally advanced non-small cell lung cancer. Fifteen CT-based measures of parenchymal, pleural and lung volume change, and anatomical distortions, were calculated. Respiratory morbidity was assessed with the Medical Research Council (MRC) dyspnoea score and spirometric pulmonary function tests (PFTs): FVC, FEV1, FEV1/FVC and DLCO.
Results:
FEV1, FEV1/FVC and MRC scores progressively declined post-RT; FVC decreased by 6-months before partially recovering. Radiologically, an early phase (3–6 months) of acute inflammation was characterised by reversible parenchymal change and non-progressive anatomical distortion. A phase of chronic scarring followed (6–24 months) with irreversible parenchymal change, progressive volume loss and anatomical distortion. Post-RT increase in contralateral lung volume was common. Normal lung volume shrinkage correlated longitudinally with mean lung dose (r = 0.30–0.40, p = 0.01–0.04). Radiological findings allowed separation of patients with predominant acute versus chronic RILD; subjects with predominantly chronic RILD had poorer pre-RT lung function.
Conclusions:
CT-based measures enable detailed quantification of the longitudinal evolution of RILD. The majority of patients developed progressive lung damage, even when the early phase was absent or mild. Pre-RT lung function and RT dosimetry may allow to identify subjects at increased risk of RILD
Viscous-Inviscid Interactions in a Boundary-Layer Flow Induced by a Vortex Array
In this paper we investigate the asymptotic validity of boundary layer
theory. For a flow induced by a periodic row of point-vortices, we compare
Prandtl's solution to Navier-Stokes solutions at different numbers. We
show how Prandtl's solution develops a finite time separation singularity. On
the other hand Navier-Stokes solution is characterized by the presence of two
kinds of viscous-inviscid interactions between the boundary layer and the outer
flow. These interactions can be detected by the analysis of the enstrophy and
of the pressure gradient on the wall. Moreover we apply the complex singularity
tracking method to Prandtl and Navier-Stokes solutions and analyze the previous
interactions from a different perspective
- …